Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CHC Healthcare GroupTPE:4164 +0.19%76 PS Ratio is 1.18 as of Aug. 03, 2026, which is 53% below its 10-year median of 2.52. GuruFocus rates TPE:4164 with a GF Score™ of 76/100 and a GF Value™ of NT$52.32 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 118 Medical Distribution companies, CHC Healthcare Group ranks worse than 77.97% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, CHC Healthcare Group's share price is NT$26.05.
CHC Healthcare Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was NT$22.11. Hence, CHC Healthcare Group's PS Ratio for today is 1.18.
Good Sign:
CHC Healthcare Group stock PS Ratio (=1.18) is close to 10-year low of 1.18.
The historical rank and industry rank for CHC Healthcare Group's PS Ratio or its related term are showing as below:
TPE:4164'
s PS Ratio Range Over the Past 10 Years
Min: 1.18 Med: 2.52 Max: 4.33
Current: 1.18
During the past 13 years, CHC Healthcare Group's highest PS Ratio was 4.33. The lowest was 1.18. And the median was 2.52.
TPE:4164's PS Ratio is ranked worse than 77.97% of 118
companies
in the Medical Distribution industry
Industry Median: 0.39
vs TPE:4164: 1.18
CHC Healthcare Group revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of CHC Healthcare Group was 0.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 13.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 12.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 2.80% per year.
During the past 13 years, CHC Healthcare Group's highest 3-Year average Revenue per Share Growth Rate was 85.10% per year. The lowest was -5.90% per year. And the median was -2.40% per year.
CHC Healthcare Group (TPE:4164) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
CHC Healthcare Group PS Ratio Related Terms
CHC Healthcare Group PS Ratio Historical Data
* Premium members only.
The historical data trend for CHC Healthcare Group's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, CHC Healthcare Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CHC Healthcare Group PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, CHC Healthcare Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where CHC Healthcare Group's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
CHC Healthcare Group's Share Price of today is NT$26.05. CHC Healthcare Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$22.11.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
CHC Healthcare Group (TPE:4164) has a PS Ratio of 1.18 as of Aug. 03, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on CHC Healthcare Group and its competitors. This is 53% below median its historical median of 2.52. Over the past decade, CHC Healthcare Group's PS Ratio has ranged from 1.18 to 4.33. According to the industry distribution chart, CHC Healthcare Group ranks #92 out of 118 companies in the Medical Distribution industry, placing it in the top 78%.
Is CHC Healthcare Group's PS Ratio too high?
CHC Healthcare Group's current PS Ratio of 1.18 is 53% below median its 10-year median of 2.52. Over the past 10 years, this metric has ranged from a low of 1.18 to a high of 4.33. The Medical Distribution industry median PS Ratio is 0.39. CHC Healthcare Group's value of 1.18 is 202.6% above this industry median. Based on the distribution chart, CHC Healthcare Group ranks #92 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, CHC Healthcare Group has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CHC Healthcare Group's PS Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, CHC Healthcare Group ranks #92 out of 118 companies for PS Ratio. This places CHC Healthcare Group in the lower half of its industry. The industry median PS Ratio is 0.39. CHC Healthcare Group's value of 1.18 is 202.6% above this benchmark. Historically, CHC Healthcare Group's own PS Ratio has ranged from 1.18 to 4.33 over the past decade. While the company's 10-year median is 2.52 vs. the industry median of 0.39, CHC Healthcare Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.39, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CHC Healthcare Group's current PS Ratio of 1.18 is 202.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on CHC Healthcare Group and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CHC Healthcare Group's current PS Ratio is 1.18, which is 53% below median its own 10-year median of 2.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CHC Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, CHC Healthcare Group (TPE:4164) is currently considered Possible Value Trap. The stock's GF Value™ is NT$52.32, compared to a current price of NT$26.05 — trading 50.2% below its estimated fair value. The current PS Ratio is 1.18, which is 53% below median its 10-year median of 2.52 and 202.6% above the Medical Distribution industry median of 0.39. CHC Healthcare Group's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For CHC Healthcare Group (TPE:4164), the current PS Ratio is 1.18 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CHC Healthcare Group (TPE:4164) Overvalued in 2026?
Based on GuruFocus' analysis, CHC Healthcare Group stock appears to be undervalued.
The current stock price of NT$26.05 is trading 50.2% below its estimated GF Value™ of NT$52.32.
GuruFocus considers CHC Healthcare Group to be Possible Value Trap.
Key valuation signals for TPE:4164:
PS Ratio: 1.18 (53% below median its 10-year median of 2.52)
GF Value™: NT$52.32 vs. price of NT$26.05 (50.2% below fair value)
Industry Position: 202.6% above the Medical Distribution median (#92 of 118)
No single metric tells the full story. See the TPE:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CHC Healthcare Group is a Taiwan-based company engaged in the trading of pharmaceutical products and health food, as well as the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment used in radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, the sale of medical instruments, repairs, maintenance, and other services.
76GF Score
Get the complete analysis for TPE:4164
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4164 has been successfully added to your 
